ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-71

  1. 125 Posts.
    lightbulb Created with Sketch. 100
    No heads need to roll, new CEO got his team and this announcement proves that they are going to
    restructure.
    Expect some news of further steps prior to the AGM to create stability and momentum,
    all IMO
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.